MICHAEL KORZI: Open Payments
NPI 1831497478 · CARNEGIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,204 in 12 payments from 11 companies in 2025. Trend: 2023 $1,370 · 2024 $1,228 · 2025 $1,204
Food & beverage: $1,204
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $239 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $118 |
| AstraZeneca Pharmaceuticals LP | 1 | $114 |
| Novo Nordisk Inc | 1 | $114 |
| Axsome Therapeutics, Inc. | 1 | $114 |
| Verona Pharma, Inc. | 1 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $103 |
| Exact Sciences Corporation | 1 | $30 |
Products named: VRAYLAR, Kerendia, VOQUEZNA, ZEPBOUND, AIRSUPRA, Wegovy, Symbravo, Ohtuvayre.
Industry payments across PA — which companies pay providers there.
